ALB ALBEMARLE CORP
Plastic Materials, Synth Resins & Nonvulcan Elastomers · NYSE · SEC CIK 915913 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY24.4%
TTM net income YoY3,321.9%
TTM EPS YoY361.0%
Revenue 3-yr CAGR-14.6%
Net income 3-yr CAGR-41.0%
Margins
Gross margin25.8%
Operating margin10.0%
Net margin11.1%
FCF margin23.5%
EBITDA margin20.5%
Returns
ROE6.6%
ROA4.1%
ROIC (approx.)2.8%
Asset turnover0.37x
Leverage & solvency
Liabilities / assets32.7%
Debt / equity0.18x
Current ratio2.34x
Interest coverage4.13x
Cash quality & payout
Operating cash flow / net income2.71x
Accruals ratio-7.0%
Payout ratio28.0%
Capex / revenue6.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20212022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $5.14B | $5.38B | $9.62B | $7.32B | $3.33B |
| Cost of revenue | $4.47B | $5.31B | $8.43B | $4.25B | $2.33B |
| Gross profit | $668.72M | $62.54M | $1.19B | $3.07B | $997.97M |
| R&D expense | $51.40M | $86.72M | $85.72M | $71.98M | $54.03M |
| SG&A expense | $550.04M | $618.05M | $910.00M | $524.14M | $441.48M |
| Operating income | -$367.08M | -$1.78B | $251.88M | $2.47B | $798.43M |
| Interest expense | $207.65M | $165.62M | $116.07M | $122.97M | $61.48M |
| Pretax income | -$552.07M | -$1.76B | $246.74M | $2.43B | $133.62M |
| Income tax | $156.88M | $87.08M | $430.28M | $390.59M | $29.45M |
| Net income | -$510.63M | -$1.18B | $1.57B | $2.69B | $123.67M |
| EBITDA | $291.59M | -$1.19B | $681.83M | $2.77B | $1.05B |
| EPS (basic) | -5.76 | -11.20 | 13.41 | 22.97 | 1.07 |
| EPS (diluted) | -5.76 | -11.20 | 13.36 | 22.84 | 1.06 |
| Dividends declared per share | 1.62 | 1.61 | 1.60 | 1.58 | 1.56 |
| Weighted avg. shares (diluted) | 117.66M | 117.52M | 117.77M | 117.79M | 116.54M |
| Balance sheet | |||||
| Cash & equivalents | $1.62B | $1.19B | $889.90M | $1.50B | $439.27M |
| Receivables | $593.50M | $742.20M | $1.21B | $1.19B | $556.92M |
| Inventory | $1.18B | $1.50B | $2.16B | $2.08B | $798.62M |
| Current assets | $4.01B | $3.84B | $5.22B | $5.19B | $1.99B |
| PP&E, net | $8.61B | $9.33B | $9.50B | $6.96B | $5.91B |
| Goodwill | $1.50B | $1.58B | $1.63B | $1.62B | $1.60B |
| Intangibles | $214.23M | $230.75M | $261.86M | $287.87M | $308.95M |
| Total assets | $16.37B | $16.61B | $18.27B | $15.46B | $10.97B |
| Current liabilities | $1.80B | $1.97B | $3.56B | $2.74B | $1.87B |
| Short-term debt | $74.08M | $398.02M | $625.76M | $2.13M | $389.92M |
| Long-term debt | $3.12B | $3.12B | $3.54B | $3.21B | $2.00B |
| Total debt | $3.19B | $3.52B | $4.17B | $3.22B | $2.39B |
| Total liabilities | $6.59B | $6.41B | $8.61B | $7.27B | $5.17B |
| Shareholders' equity | $9.53B | $9.96B | $9.41B | $7.98B | $5.63B |
| Net debt | $1.58B | $2.32B | $3.28B | $1.72B | $1.95B |
| Shares outstanding | 117.72M | 117.56M | 117.36M | 117.17M | 117.02M |
| Cash flow statement | |||||
| Operating cash flow | $1.28B | $687.88M | $1.33B | $1.91B | $344.26M |
| Capital expenditure | $589.80M | $1.68B | $2.15B | $1.26B | $953.67M |
| Free cash flow | $692.47M | -$992.65M | -$827.96M | $646.20M | -$609.41M |
| Investing cash flow | -$146.01M | -$1.58B | -$2.56B | -$1.42B | -$666.59M |
| Financing cash flow | -$834.19M | $1.24B | $623.91M | $611.89M | $50.21M |
| Depreciation & amortization | $658.68M | $588.64M | $429.94M | $300.84M | $254.00M |
| Stock-based compensation | $40.27M | $32.14M | $36.55M | $30.47M | $20.12M |
| Dividends paid | $190.53M | $188.53M | $187.19M | $184.43M | $177.85M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.